Mouse Anti-CST1 Recombinant Antibody (C0615) (CBMAB-C0615-LY)

Ding, J., Wang, X., Gao, J., & Song, T. (2021). Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open bio, 11(8), 2186-2197.

Fukuoka, A., Matsushita, K., Morikawa, T., Adachi, T., Yasuda, K., Kiyonari, H., ... & Yoshimoto, T. (2019). Human cystatin SN is an endogenous protease inhibitor that prevents allergic rhinitis. Journal of Allergy and Clinical Immunology, 143(3), 1153-1162.

Yan, B., Lou, H., Wang, Y., Li, Y., Meng, Y., Qi, S., ... & Zhang, L. (2019). Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology, 144(2), 455-469.

Liu, Y., & Yao, J. (2019). Research progress of cystatin SN in cancer. OncoTargets and therapy, 12, 3411.

Liu, Y., Ma, H., Wang, Y., Du, X., & Yao, J. (2019). Cystatin SN affects cell proliferation by regulating the ERα/PI3K/AKT/ERα loopback pathway in breast cancer. OncoTargets and therapy, 12, 11359.

Mueller, S. K., Nocera, A. L., Dillon, S. T., Gu, X., Wendler, O., Otu, H. H., ... & Bleier, B. S. (2019, February). Noninvasive exosomal proteomic biosignatures, including cystatin SN, peroxiredoxin‐5, and glycoprotein VI, accurately predict chronic rhinosinusitis with nasal polyps. In International Forum of Allergy & Rhinology (Vol. 9, No. 2, pp. 177-186).

Cui, Y., Sun, D., Song, R., Zhang, S., Liu, X., Wang, Y., ... & Liu, L. (2019). Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis. Journal of Cellular Physiology, 234(12), 22623-22634.

Oh, S. S., Park, S., Lee, K. W., Madhi, H., Park, S. G., Lee, H. G., ... & Dong Kim, K. (2017). Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation. Cell death & disease, 8(4), e2729-e2729.

Oh, B. M., Lee, S. J., Cho, H. J., Park, Y. S., Kim, J. T., Yoon, S. R., ... & Lee, H. G. (2017). Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer. Cell death & disease, 8(3), e2682-e2682.

Li, T., Xiong, Q., Zou, Z., Lei, X., Jiang, Q., & Liu, D. (2017). Prognostic significance of cystatin SN associated nomograms in patients with colorectal cancer. Oncotarget, 8(70), 115153.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols